We are live on ! Find out more
CIC

Chase Investment Counsel Portfolio holdings

AUM $474M
1-Year Est. Return 95.11%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+95.11%
3 Year Est. Return
+349.64%
5 Year Est. Return
+621.11%
10 Year Est. Return
+3,935.08%
AUM
$273M
AUM Growth
-$38.4M
Cap. Flow
-$31.3M
Cap. Flow %
-11.45%
Top 10 Hldgs %
27.33%
Holding
154
New
20
Increased
23
Reduced
53
Closed
32

Top Buys

Rank Stock Value
1
CLS icon
Celestica
CLS
+$6.94M
2
CRS icon
Carpenter Technology
CRS
+$6.29M
3
MCK icon
McKesson
MCK
+$6.27M
4
GLW icon
Corning
GLW
+$6.12M
5
LH icon
Labcorp
LH
+$6M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.27M
2
AAPL icon
Apple
AAPL
+$6.98M
3
TMUS icon
T-Mobile US
TMUS
+$6.78M
4
FLS icon
Flowserve
FLS
+$6.14M
5
ARES icon
Ares Management
ARES
+$5.83M

Sector Composition

Rank Sector Weight
1 Technology 22.66%
2 Financials 19.78%
3 Healthcare 13.15%
4 Consumer Discretionary 10.95%
5 Industrials 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
51
United Therapeutics
UTHR
$22.1B
$1.66M 0.61%
5,375
+4,000
+291% +$1.37M
ACGL icon
52
Arch Capital
ACGL
$33.5B
$1.54M 0.56%
16,009
-28,594
-64% -$2.64M
DHI icon
53
D.R. Horton
DHI
$42.2B
$1.52M 0.56%
12,000
+1,200
+11% +$161K
ULTA icon
54
Ulta Beauty
ULTA
$23.3B
$1.47M 0.54%
4,000
AMP icon
55
Ameriprise Financial
AMP
$49.7B
$1.45M 0.53%
3,000
+1,000
+50% +$524K
HRB icon
56
H&R Block
HRB
$5.92B
$1.32M 0.48%
24,000
+3,000
+14% +$160K
CPRX
57
DELISTED
Catalyst Pharmaceutical
CPRX
$1.31M 0.48%
54,000
INVA icon
58
Innoviva
INVA
$1.5B
$1.27M 0.46%
70,000
-10,000
-13% -$179K
WSM icon
59
Williams-Sonoma
WSM
$29.5B
$1.26M 0.46%
8,000
-6,000
-43% -$1.16M
YETI icon
60
Yeti Holdings
YETI
$3.85B
$1.26M 0.46%
38,000
ARKB icon
61
ARK 21Shares Bitcoin ETF
ARKB
$2.42B
$1.22M 0.45%
44,676
ACLS icon
62
Axcelis
ACLS
$4.18B
$1.19M 0.44%
24,000
+9,000
+60% +$569K
SQM icon
63
Sociedad Química y Minera de Chile
SQM
$20.6B
$1.19M 0.44%
30,000
PCAR icon
64
PACCAR
PCAR
$69.8B
$1.17M 0.43%
12,000
-200
-2% -$21.1K
ANET icon
65
Arista Networks
ANET
$250B
$1.1M 0.4%
14,190
-51,540
-78% -$5.23M
TOL icon
66
Toll Brothers
TOL
$14.3B
$1.05M 0.39%
10,000
FTNT icon
67
Fortinet
FTNT
$119B
$1.05M 0.38%
10,909
ABBV icon
68
AbbVie
ABBV
$442B
$1.02M 0.37%
4,882
-18
-0.4% -$3.5K
APAM icon
69
Artisan Partners
APAM
$3.08B
$1.02M 0.37%
26,000
SNA icon
70
Snap-on
SNA
$21.3B
$1.01M 0.37%
3,000
-1,000
-25% -$340K
NMIH icon
71
NMI Holdings
NMIH
$3.34B
$918K 0.34%
25,485
-3,527
-12% -$128K
GILD icon
72
Gilead Sciences
GILD
$168B
$890K 0.33%
7,945
MRK icon
73
Merck
MRK
$322B
$792K 0.29%
8,826
-25
-0.3% -$2.33K
TBBK icon
74
The Bancorp
TBBK
$2.83B
$766K 0.28%
+14,501
New +$805K
EME icon
75
Emcor
EME
$36B
$724K 0.27%
1,961
-36
-2% -$15.6K

Similar funds

Chase Investment Counsel's Q1 2025 Portfolio in Review

As of Q1 2025, Chase Investment Counsel held 154 positions worth $273M, down 12% from $311M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Chase Investment Counsel withdrew a net $31.3M in Q1 2025, closing 32 positions and reducing 53 holdings. Its most notable exit was Flowserve, an estimated $6.14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Chase Investment Counsel opened a new position in McKesson worth $6.83M.

  • Chase Investment Counsel's largest Q1 2025 buy was McKesson: 10,145 shares worth $6.83M.
  • Chase Investment Counsel added most to Celestica in Q1 2025, an estimated $6.94M increase.
  • Chase Investment Counsel's biggest Q1 2025 reduction was Microsoft, cutting an estimated $9.27M.
  • Chase Investment Counsel fully exited Flowserve in Q1 2025, selling an estimated $6.14M.
  • Chase Investment Counsel's ten largest holdings make up 27% of its $273M portfolio in Q1 2025.
  • Chase Investment Counsel opened 20 new positions and closed 32 in Q1 2025.
  • Chase Investment Counsel's portfolio value fell 12% quarter-over-quarter to $273M.

Based on Chase Investment Counsel's 13F filing for Q1 2025, filed 12 May 2025.